| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-13 11:52:41 UTC |
|---|
| Update Date | 2021-09-14 15:40:15 UTC |
|---|
| HMDB ID | HMDB0042005 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Quinaprilat |
|---|
| Description | Quinaprilat is the active metabolite of quinapril. Quinapril is a prodrug and is a long-acting, non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor used in the treatment of arterial hypertension or chronic heart failure (PMID: 19761414 ). Prodrugs are compounds that must be metabolized in the gut or liver before they can become active. Quinaprilat functions through blocking the conversion of angiotensin I to the vasoconstrictor angiotensin II, thereby inhibiting bradykinin degradation which reduces vascular oxidative stress and endothelial activity (PMID: 15223904 ). It is eliminated mainly in urine. It has no teratogenic, mutagenic or carcinogenic effect. Quinaprilat is only found in individuals who have taken or consumed the drug quinapril. |
|---|
| Structure | [H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CC2=CC=CC=C2C[C@@]1([H])C(O)=O InChI=1S/C23H26N2O5/c1-15(24-19(22(27)28)12-11-16-7-3-2-4-8-16)21(26)25-14-18-10-6-5-9-17(18)13-20(25)23(29)30/h2-10,15,19-20,24H,11-14H2,1H3,(H,27,28)(H,29,30)/t15-,19-,20-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| CI 928 | ChEBI | | CI-928 | ChEBI | | CI928 | ChEBI | | CL-928 | ChEBI | | Quinaprilate | ChEBI | | Quinaprilatum | ChEBI | | Quinaprilic acid | Generator | | CI-928quinaprilat | HMDB | | 2-(2-((1-Carboxy-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid | HMDB | | Quinaprilat, (3S-(2(r*(r*)),3R*))-isomer | HMDB |
|
|---|
| Chemical Formula | C23H26N2O5 |
|---|
| Average Molecular Weight | 410.4629 |
|---|
| Monoisotopic Molecular Weight | 410.184171952 |
|---|
| IUPAC Name | (3S)-2-[(2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid |
|---|
| Traditional Name | quinaprilat |
|---|
| CAS Registry Number | 82768-85-2 |
|---|
| SMILES | [H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CC2=CC=CC=C2C[C@@]1([H])C(O)=O |
|---|
| InChI Identifier | InChI=1S/C23H26N2O5/c1-15(24-19(22(27)28)12-11-16-7-3-2-4-8-16)21(26)25-14-18-10-6-5-9-17(18)13-20(25)23(29)30/h2-10,15,19-20,24H,11-14H2,1H3,(H,27,28)(H,29,30)/t15-,19-,20-/m0/s1 |
|---|
| InChI Key | FLSLEGPOVLMJMN-YSSFQJQWSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- N-acyl-l-alpha-amino acid
- Alpha-amino acid amide
- Alpha-amino acid
- Alpha-amino acid or derivatives
- Tetrahydroisoquinoline
- L-alpha-amino acid
- Aralkylamine
- Monocyclic benzene moiety
- Dicarboxylic acid or derivatives
- Benzenoid
- Tertiary carboxylic acid amide
- Amino acid or derivatives
- Carboxamide group
- Amino acid
- Organoheterocyclic compound
- Azacycle
- Carboxylic acid
- Secondary aliphatic amine
- Secondary amine
- Organopnictogen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Amine
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.36 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.4729 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.39 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 101.7 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1855.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 213.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 171.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 169.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 128.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 448.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 454.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 259.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1003.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 509.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1346.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 283.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 315.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 260.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 185.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 54.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Quinaprilat,1TMS,isomer #1 | C[C@H](N[C@@H](CCC1=CC=CC=C1)C(=O)O[Si](C)(C)C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O | 3284.0 | Semi standard non polar | 33892256 | | Quinaprilat,1TMS,isomer #2 | C[C@H](N[C@@H](CCC1=CC=CC=C1)C(=O)O)C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O[Si](C)(C)C | 3303.0 | Semi standard non polar | 33892256 | | Quinaprilat,1TMS,isomer #3 | C[C@@H](C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O)N([C@@H](CCC1=CC=CC=C1)C(=O)O)[Si](C)(C)C | 3293.6 | Semi standard non polar | 33892256 | | Quinaprilat,2TMS,isomer #1 | C[C@H](N[C@@H](CCC1=CC=CC=C1)C(=O)O[Si](C)(C)C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O[Si](C)(C)C | 3223.8 | Semi standard non polar | 33892256 | | Quinaprilat,2TMS,isomer #2 | C[C@@H](C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O)N([C@@H](CCC1=CC=CC=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 3227.4 | Semi standard non polar | 33892256 | | Quinaprilat,2TMS,isomer #3 | C[C@@H](C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O[Si](C)(C)C)N([C@@H](CCC1=CC=CC=C1)C(=O)O)[Si](C)(C)C | 3211.1 | Semi standard non polar | 33892256 | | Quinaprilat,3TMS,isomer #1 | C[C@@H](C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O[Si](C)(C)C)N([C@@H](CCC1=CC=CC=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 3223.7 | Semi standard non polar | 33892256 | | Quinaprilat,3TMS,isomer #1 | C[C@@H](C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O[Si](C)(C)C)N([C@@H](CCC1=CC=CC=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 3210.5 | Standard non polar | 33892256 | | Quinaprilat,1TBDMS,isomer #1 | C[C@H](N[C@@H](CCC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O | 3548.2 | Semi standard non polar | 33892256 | | Quinaprilat,1TBDMS,isomer #2 | C[C@H](N[C@@H](CCC1=CC=CC=C1)C(=O)O)C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3568.5 | Semi standard non polar | 33892256 | | Quinaprilat,1TBDMS,isomer #3 | C[C@@H](C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O)N([C@@H](CCC1=CC=CC=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 3578.0 | Semi standard non polar | 33892256 | | Quinaprilat,2TBDMS,isomer #1 | C[C@H](N[C@@H](CCC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3721.7 | Semi standard non polar | 33892256 | | Quinaprilat,2TBDMS,isomer #2 | C[C@@H](C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O)N([C@@H](CCC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3764.8 | Semi standard non polar | 33892256 | | Quinaprilat,2TBDMS,isomer #3 | C[C@@H](C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([C@@H](CCC1=CC=CC=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 3761.7 | Semi standard non polar | 33892256 | | Quinaprilat,3TBDMS,isomer #1 | C[C@@H](C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([C@@H](CCC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3947.4 | Semi standard non polar | 33892256 | | Quinaprilat,3TBDMS,isomer #1 | C[C@@H](C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([C@@H](CCC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3812.1 | Standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Quinaprilat GC-MS (Non-derivatized) - 70eV, Positive | splash10-0403-2925000000-e4de4c2b1f51a90ebc34 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Quinaprilat GC-MS (2 TMS) - 70eV, Positive | splash10-000i-9642440000-3935bd20baf3ed736d1d | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Quinaprilat GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Quinaprilat 10V, Positive-QTOF | splash10-03xu-0239400000-657f7ef4a13d754d6019 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Quinaprilat 20V, Positive-QTOF | splash10-0a4i-1953000000-6560d0372a2a1dd70171 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Quinaprilat 40V, Positive-QTOF | splash10-03ec-2900000000-89636c81c5cbbdc3ef6d | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Quinaprilat 10V, Negative-QTOF | splash10-0aor-0009500000-9c12c7c6c289ed26d187 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Quinaprilat 20V, Negative-QTOF | splash10-0690-0529100000-5ebce1d9aed5907f8abf | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Quinaprilat 40V, Negative-QTOF | splash10-02e9-1910000000-df2dae9a4c8d21668f20 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Quinaprilat 10V, Positive-QTOF | splash10-03di-0125900000-de537442df409f3872dc | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Quinaprilat 20V, Positive-QTOF | splash10-014i-0319100000-0d99754c5f3bea7a6b30 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Quinaprilat 40V, Positive-QTOF | splash10-02u3-2900000000-67e4c42bed2130a5a52d | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Quinaprilat 10V, Negative-QTOF | splash10-0a4i-0114900000-c3d294563f563dcc6f6d | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Quinaprilat 20V, Negative-QTOF | splash10-057i-0911100000-7452d726559f5d57738a | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Quinaprilat 40V, Negative-QTOF | splash10-0m0x-2910000000-ad031a0b0ef9b18dd397 | 2021-09-23 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Kieback AG, Felix SB, Reffelmann T: Quinaprilat: a review of its pharmacokinetics, pharmacodynamics, toxicological data and clinical application. Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1337-47. doi: 10.1517/17425250903282773. [PubMed:19761414 ]
- Steinhauff S, Pehlivanli S, Bakovic-Alt R, Meiser BM, Becker BF, von Scheidt W, Weis M: Beneficial effects of quinaprilat on coronary vasomotor function, endothelial oxidative stress, and endothelin activation after human heart transplantation. Transplantation. 2004 Jun 27;77(12):1859-65. doi: 10.1097/01.tp.0000131148.78203.b7. [PubMed:15223904 ]
|
|---|